Autobahn Therapeutics, Inc. Information
Contact top employees from
Autobahn Therapeutics, Inc.
Summary
Autobahn Therapeutics, Inc. is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the Chairman & CEO is occupied by Kevin Finney. Its headquarters is located at San Diego, California, USA. The number of employees ranges from 25 to 100. The annual revenue of Autobahn Therapeutics, Inc. varies between 100K and 5.0M. Total funding of the company - $76M. To connect with Autobahn Therapeutics, Inc. employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
DMA Code
San Diego County
Founded
2017
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Contact Autobahn Therapeutics, Inc.
Organization Website
Social Links
Phone Number
858-722-0037
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2014 | Public Company | 100 - 250 | 132.2M | $267.1M | |
| 2002 | Public Company | 25 - 100 | 126.9M | $20.1M | |
| 2003 | Public Company | 25 - 100 | < 1M | $45M | |
| 2006 | Public Company | 100 - 250 | 7.5M | $557.6M | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 1993 | Public Company | 500 - 1.0K | 573.5M | $201M | |
| 2015 | Public Company | 25 - 100 | 10M | $13.9M | |
| 2010 | Public Company | 100 - 250 | 62.1M | $528.9M | |
| 2010 | Public Company | 250 - 500 | 1.1B | $843M | |
| 2004 | Public Company | 100 - 250 | 6.5M | $610M | |
| 1948 | Public Company | 1.0K - 5.0K | 682.4M | $320.5M | |
| 2016 | Privately Held | 1 - 25 | < 1M | $156.6M | |
| 2001 | Public Company | 25 - 100 | 5M | $181.3M | |
| 2001 | Privately Held | 100 - 250 | 5M | $126.7M | |
| 2007 | Public Company | 1 - 25 | 41.2M | $124.3M | |
| 2015 | Privately Held | 1 - 25 | 7M | $8.3M | |
| 2008 | Privately Held | 25 - 100 | < 1M | $264.4M | |
| 1948 | Public Company | 10K - 50K | 16B | $31.1M | |
| 1830 | Public Company | 50K - 100K | 45.5B | $0 | |
| 2005 | Privately Held | 25 - 100 | 17.1M | $0 | |
| 1876 | Public Company | 10K - 50K | 26.7B | $0 | |
| 1998 | - | 1 - 25 | 17.9M | $0 | |
| 2012 | - | 200-500 | - | $- | |
| 2022 | - | 200-500 | - | $- | |
| 2007 | - | 100-200 | - | $- | |
| 2008 | - | 200-500 | - | $- | |
| - | - | 500-1000 | - | $- |
Estimated Website Traffic
The chart shows a growth in traffic to the autobahntx.com website. In September, traffic increased to 675, compared to 669 in the previous month. The highest traffic in 2025 was recorded in July, reaching 1844 visits.
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Autobahn Therapeutics, Inc. shows a diverse range of experience levels:
8% have been with the company for less than 1 year17% for 1–2 years33% for 3–4 years42% for 5–7 yearsEx-employees positions
In Company
In New Company
Contact top employees from
Autobahn Therapeutics, Inc.
Bridgette Boggess Franey
Executive Medical Director, Global Medical Lead-Clinical Development
Alida Barry
Vice President, Head of Regulatory Affairs
Michelle Hillstrand
Senior Manager Clinical Operations
Regina Griffin
Sr. Manager, Clinical Operations
Betsy Vaughn
Vice President, Talent and Culture
Aryan Alavi
Associate Scientist
Elizabeth Burnette PhD
Sr. Manager, Clinical Science Liaison
Kevin Finney
Chairman and CEO
Christine Bryant
Director, Clinical Science
David Herman
Head of Clinical Development
James Robinson
VP, Biostatistics & Data Sciences
John Borkholder
General Counsel & SVP, Administration
Jason Harris
VP, Head of Preclinical Research
Will Stratton
VP, Corporate Development and Strategy
Jill Baccei
Senior Director, Preclinical Research
Patrick Flavin
Director, Corporate Development & Strategy
Nicola Ellis
Senior Director, Accounting and Administration
Kory George
Director, CMC
Jeffrey Vivian
Executive Director - Translational Neuroscience
Siraj Khan
Onsite Support
Similar Companies
FAQ
Autobahn Therapeutics, Inc. operates in the Biotechnology industries. More details can be found on the official website: autobahntx.com.
The headquarters of Autobahn Therapeutics, Inc. are located in San Diego, United States.
The current CEO of Autobahn Therapeutics, Inc. is Kevin Finney
You can contact Autobahn Therapeutics, Inc. by phone at 858-722-0037.
Autobahn Therapeutics, Inc. currently employs 10-50 people.
Autobahn Therapeutics, Inc.'s revenue is approximately 3.5M.
Well-known competitors of Autobahn Therapeutics, Inc. include Voyager Therapeutics, Inc., Catalyst Pharmaceuticals, Inc., Intec Pharma Ltd. and Avalanche Biotechnologies, Inc..
